Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients

PROG-IMT and the Proof-ATHERO Study Groups

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)621-642
Number of pages22
JournalCirculation
Volume142
Issue number7
DOIs
Publication statusPublished - 18 Aug 2020

Keywords

  • cardiovascular disease
  • carotid intima-media thickness
  • clinical trials as topic
  • surrogate marker
  • meta-analysis
  • BASE-LINE CHARACTERISTICS
  • TYPE-2 DIABETES-MELLITUS
  • IMPAIRED GLUCOSE-TOLERANCE
  • CORONARY-HEART-DISEASE
  • JAPAN STATIN TREATMENT
  • LDL TREATMENT STRATEGIES
  • EXTENDED-RELEASE NIACIN
  • ESTROGEN PLUS PROGESTIN
  • ARTERIAL-WALL THICKNESS
  • HIV-INFECTED PATIENTS

Cite this